Zobrazeno 1 - 10
of 271
pro vyhledávání: '"N., Papandreou"'
Autor:
Panagiotis J. Vlachostergios, Konstantinos Dimitropoulos, Louis L. Pisters, Christos N. Papandreou, Danai Daliani, Anastasios Karatzas, Argiro Petsiti, Vassilios Tassoudis, Eleni Arnaoutoglou, Vassilios Tzortzis
Publikováno v:
Current Cancer Drug Targets. 23
Aim: Enhanced Recovery After Surgery (ERAS) protocols have been proven to optimize postoperative outcomes; however, misuse of opioid analgesics can still hinder postoperative recovery due to related side effects and potential complications. Introduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32cd5adc45154e6405b0bae218021787
https://doi.org/10.2174/1568009623666230426093255
https://doi.org/10.2174/1568009623666230426093255
Autor:
Panagiotis J. Vlachostergios, Athanasios Karathanasis, Christos N. Papandreou, Vassilios Tzortzis
Publikováno v:
World Journal of Oncology
Background Neuroendocrine differentiation (NED) of prostate cancer (PC) is a process that often occurs under evolutionary pressure from pharmacologic blockade of androgen receptor signaling at advanced stages of the disease. Identifying a subset of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f7535aada42662ae04877198e54db9
http://europepmc.org/articles/PMC8734499
http://europepmc.org/articles/PMC8734499
Publikováno v:
Biomolecules, Vol 2, Iss 2, Pp 240-255 (2012)
SUMO (small ubiquitin-related modifier) conjugation is a reversible three-step process of protein post-translational modifications mediating protein-protein interactions, subcellular compartmentalization and regulation of transcriptional events. Amon
Externí odkaz:
https://doaj.org/article/22dee9e33809495285712c7d2c6626cc
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation therapies, and at the c
Externí odkaz:
https://doaj.org/article/97a08a8e7a714a499097b5326fcc57d8
Autor:
Athanasios Kotsakis, Christos N. Papandreou, Ioannis Boukovinas, Vasiliki Michalaki, Christos Christodoulou, Vasiliki Sidiropoulou, Gerasimos Aravantinos, Antonios Avgerinos, Paris Kosmidis, Nikolaos Androulakis, Olga Kousidou
Publikováno v:
Anticancer Research. 40:435-441
AIM The purpose of the Imadje study was to confirm the efficacy and safety of imatinib, following resection of kit-positive gastrointestinal stromal tumour (GIST), in the adjuvant setting in the Greek population. PATIENTS AND METHODS A total of 34 ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738db9fc4601407bb7e7a5a26a08c39e
https://doi.org/10.21873/anticanres.13971
https://doi.org/10.21873/anticanres.13971
Autor:
Nikolaos Ziras, C. Kalofonos, Christos N. Papandreou, Pavlos Papakotoulas, Ioannis Boukovinas, Georgios Koumakis, Georgios Samelis, Helen Stergiou, Eleni Timotheadou, Evangelos Bournakis, Athina Christopoulou, Georgios Papatsimpas, Athanasios Athanasiadis, Gerasimos Aravantinos, Alexandros Bokas, Alexandros Ardavanis, Paris Makrantonakis, Ioannis Varthalitis, Maria Souggleri, Pavlos Papakostas, Epameinondas Samantas, Charalambos Andreadis, Nikolaos Tsoukalas, Anastasios Grivas, Sofia Tripodaki, Georgios Pentheroudakis
Publikováno v:
Anticancer Research. 40:305-313
Background Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according to guidelines. Patients and methods A multicenter prospective observational stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d297226a7d59f608becc1a78c7d9c8ab
https://doi.org/10.21873/anticanres.13954
https://doi.org/10.21873/anticanres.13954
Autor:
Christos Liaskos, Eirini I. Rigopoulou, Timoklia Orfanidou, Dimitrios P. Bogdanos, Christos N. Papandreou
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
CUZD1, the CUB, and zona pellucida-like domains-containing protein 1, is a newly identified antigen of pancreatic autoantibodies (PAB) giving a reticulogranular pattern in patients with inflammatory bowel diseases, and in particular Crohn’s disease
Externí odkaz:
https://doaj.org/article/6af6ecc85ad946d4a87531805b922a54
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Autor:
Evangelos Bournakis, Athanasios Athanasiadis, Epameinondas Samantas, Gerasimos Aravantinos, Christos N. Papandreou, Georgios Samelis, Charalambos Andreadis, Maria Souggleri, Anastasios Grivas, Elli-Sofia Tripodaki, Georgios Koumakis, Nikolaos Ziras, Helen Stergiou, Eleni Timotheadou, Nikolaos Tsoukalas, Georgios Papatsimpas, Ioannis Varthalitis, Paris Makrantonakis, Alexandros Bokas, C. Kalofonos, Ioannis Boukovinas, Alexandros Ardavanis, Pavlos Papakostas, P. Papakotoulas, Athina Christopoulou, Georgios Pentheroudakis
Publikováno v:
Cancers, Vol 12, Iss 1907, p 1907 (2020)
Cancers
Volume 12
Issue 7
Cancers
Volume 12
Issue 7
Background: Cancer patients are at high risk for cancer-associated thrombosis (CAT). CAT is the second leading cause of death in these patients but it can be preventable with thromboprophylaxis. Patients and Methods: An observational, prospective, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c69b406e149627e5605c25268fa6004
https://www.mdpi.com/2072-6694/12/7/1907
https://www.mdpi.com/2072-6694/12/7/1907
Autor:
Panagiotis J. Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, George Moutzouris, Anna Patrikidou, Ioannis A. Voutsadakis, Danai D. Daliani, Elias Zintzaras, Michael D. Melekos, Christos N. Papandreou
Publikováno v:
Prostate Cancer, Vol 2012 (2012)
Objective. To study the impact of the neutral endopeptidase (NEP)/neuropeptides (NPs) axis and nuclear factor kappa B (NFκB) as predictors of prostate-specific antigen (PSA) recurrence after radical prostatectomy (RP). Patients and Methods. 70 patie
Externí odkaz:
https://doaj.org/article/b646f1f4afa34ee8965f58c43385ab5c
Autor:
P. Papakotoulas, Athina Christopoulou, Nikolaos Tsoukalas, Alexandros Bokas, Athanasios Athanasiadis, Stavros D. Peroukidis, Alexandros Ardavanis, Achilleas Nikolakopoulos, Epaminontas Samantas, Nikolaos K. Kentepozidis, G. Anastopoulou, N. Kapodistrias, C. Andreadis, Ilias Athanasiadis, Eleni Timotheadou, D. Mavroudis, Anna Koumarianou, I. Boukovinas, Amanda Psyrri, V. Barbounis, Georgios Samelis, Christos N. Papandreou
Publikováno v:
Annals of Oncology. 32:S172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f75b63feac174f2fc7d1e31f4c284ff
https://doi.org/10.1016/j.annonc.2021.05.268
https://doi.org/10.1016/j.annonc.2021.05.268